Published in J Cardiovasc Electrophysiol on June 26, 2012
Electrophysiological studies in patients with pulmonary hypertension: a retrospective investigation. Biomed Res Int (2014) 0.77
Ablation of atrial flutter in severe pulmonary hypertension: pushing the outside of the envelope. J Cardiovasc Electrophysiol (2012) 0.75
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: General management for pulmonary hypertension. Ann Thorac Med (2014) 0.75
Medical schools in sub-Saharan Africa. Lancet (2010) 8.85
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol (2012) 5.46
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
Tadalafil therapy for pulmonary arterial hypertension. Circulation (2009) 2.98
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol (2013) 2.58
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation (2010) 2.26
Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2003) 2.23
Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia. Heart Rhythm (2006) 2.18
Impact of local ablation on interconnected channels within ventricular scar: mechanistic implications for substrate modification. Circ Arrhythm Electrophysiol (2013) 2.15
The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis (2008) 2.09
Use of thoracic epidural anesthesia for management of electrical storm: a case report. Heart Rhythm (2005) 2.07
Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension. Chest (2013) 1.98
Sympathetic innervation of the anterior left ventricular wall by the right and left stellate ganglia. Heart Rhythm (2012) 1.93
Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia. Circ Arrhythm Electrophysiol (2012) 1.89
Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol (2007) 1.83
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
A survey of Sub-Saharan African medical schools. Hum Resour Health (2012) 1.78
Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm (2012) 1.77
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 1.72
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med (2010) 1.69
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing Clin Electrophysiol (2014) 1.60
Mode and mechanisms of death after orthotopic heart transplantation. Heart Rhythm (2009) 1.60
Percutaneous intrapericardial echocardiography during catheter ablation: a feasibility study. Heart Rhythm (2006) 1.57
Catheter ablation of right ventricular outflow tract tachycardia: value of defining coronary anatomy. J Cardiovasc Electrophysiol (2006) 1.57
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
Impedance monitoring during catheter ablation of atrial fibrillation. Heart Rhythm (2005) 1.49
Catheter ablation of atrial fibrillation. Circulation (2012) 1.47
A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia. Heart Rhythm (2013) 1.46
Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. J Crit Care (2012) 1.45
The Cardiac Atlas Project--an imaging database for computational modeling and statistical atlases of the heart. Bioinformatics (2011) 1.44
Unipolar and bipolar electrogram characteristics predict exit block during pulmonary vein antral isolation. Pacing Clin Electrophysiol (2012) 1.43
Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol (2013) 1.43
Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms. Circ Arrhythm Electrophysiol (2013) 1.40
Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm. Catheter Cardiovasc Interv (2010) 1.39
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol (2011) 1.35
Supraventricular tachycardia after orthotopic cardiac transplantation. J Am Coll Cardiol (2008) 1.35
Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol (2010) 1.35
Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol (2012) 1.32
Pacemaker and defibrillator lead extraction. Circulation (2011) 1.29
Distinguishing epicardial fat from scar: analysis of electrograms using high-density electroanatomic mapping in a novel porcine infarct model. Heart Rhythm (2009) 1.24
Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J (2005) 1.24
A novel method for preventing phrenic nerve injury during catheter ablation. Heart Rhythm (2006) 1.17
Percutaneous epicardial mapping during ablation of difficult accessory pathways as an alternative to cardiac surgery. Heart Rhythm (2004) 1.15
Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm (2010) 1.15
Radiofrequency current delivery via transseptal needle to facilitate septal puncture. Heart Rhythm (2007) 1.15
Irreversible intrapulmonary vascular changes after pulmonary vein stenosis complicating catheter ablation for atrial fibrillation. Cardiovasc Pathol (2007) 1.13
A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J (2006) 1.11
Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care (2006) 1.10
Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging (2010) 1.09
The predictive role of blood glucose for mortality in subjects with cardiovascular disease. Am J Epidemiol (2005) 1.09
Ultra high-density multipolar mapping with double ventricular access: a novel technique for ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (2011) 1.09
Pleuropericardial fistula formation after prior epicardial catheter ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol (2012) 1.08
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm (2014) 1.08
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. J Clin Pharmacol (2008) 1.07
Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am J Physiol Heart Circ Physiol (2012) 1.06
Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. Am J Physiol Heart Circ Physiol (2013) 1.05
Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med (2006) 1.05
Signal-averaged electrocardiogram in Ebstein's anomaly. Am J Cardiol (2004) 1.04